SenesTech, Inc. (NASDAQ:SNES) Files An 8-K Submission of Matters to a Vote of Security Holders
Item 5.07 Submission of Matters to a Vote of Security Holders.
(a) The Company held its 2019 Annual Meeting of Stockholders (the “Annual Meeting”) on Tuesday, June 18, 2019, in Phoenix, Arizona.
(b) The final results of voting for each matter submitted to a vote of stockholders at the Annual Meeting are as follows:
Proposal 1: Election of Directors
Loretta P. Mayer, Ph.D., Matthew Szot and Kenneth Siegel were elected as Class III directors, each to serve for a three-year term until the annual meeting of stockholders to be held in 2022 and until her or his successor is duly elected and qualified. The final voting results are set forth below:
| Nominee | For | Withheld | Broker Non-Votes |
| Loretta P. Mayer, Ph.D | 5,653,203 | 232,679 | 13,145,955 |
| Matthew Szot | 5,544,336 | 341,546 | 13,145,955 |
| Kenneth Siegel | 5,675,600 | 210,282 | 13,145,955 |
Proposal 2: Ratification of the appointment of M&K CPAS, PLLC as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2019
The proposal to ratify the appointment of M&K CPAs, PLLC was approved, and the final voting results are set forth below:
| For | Against | Abstain |
| 18,952,215 | 16,032 | 63,590 |
About SenesTech, Inc. (NASDAQ:SNES)
SenesTech, Inc. is a platform biotechnology company. The Company is engaged in developing a technology for managing animal pest populations through fertility control. Its approach is designed to manage food security and manage infrastructure damage, disease outbreaks, environmental contamination and other costs associated with rodent infestations. Its fertility control product candidate, ContraPest, will be marketed for use in controlling rat populations. ContraPest targets the reproductive capabilities of rodents by inducing the gradual loss of eggs in female rodents and disruption of sperm in male rodents, resulting in contraception that can progress to sterility in both females and males. The Company applies its technology to manage rats in urban and agricultural settings. It has a pipeline of fertility control and animal health products, which include ContraPest, Plant-based fertility control, Feral animal fertility control, Boar taint, and Non-Surgical Spay and Neutering.